Target intelligence / Profile preview

Erythroid Cell Proliferation

Molecular classification: Other

Overview

Erythroid cell proliferation refers to the process by which erythroid progenitor cells undergo repeated cell divisions, expanding their population before differentiating into mature erythrocytes. This process is a critical component of erythropoiesis. Proliferation is highly dependent on extracellular signals such as erythropoietin (Epo) during early stages. Key regulators include Epo, ETO2, and TR4 Nuclear Receptor. Proliferation index can be measured using Ki-67. Abnormal proliferation can be observed in certain myeloid neoplasms.

Biological functions

Cell proliferationErythropoiesis

Disease associations

Myeloid neoplasmsAnemia

Interacting drugs

Erythropoietin

Biomarkers

Ki-67 index

Beyond the preview

Go deeper on Erythroid Cell Proliferation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Erythroid Cell Proliferation.

Explore the full profile